Phase 2 Motor Neurone Disease Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with ALS (also known as Lou Gehrig's disease) by a study doctor, confirmed through specific diagnostic criteria.
• People who are between 21 and 80 years of age (inclusive).
• People who are taking the ALS medication riluzole must have been on a stable, unchanged dose for at least 30 days before the first study visit.
• People who are willing and able to read and sign a consent form that has been reviewed and approved by an ethics review board.

Who may not be able to join:

• People who have been diagnosed with another brain or nervous system disease, such as Parkinson's disease or Alzheimer's disease.
• People who have had a serious or unstable medical condition in the past 30 days, such as unstable chest pain or advanced cancer.
• People who have HIV (human immunodeficiency virus).
• People who do not have the mental capacity to sign a consent form or follow the study procedures.
• People who have a recent history of alcohol or drug misuse, or who have not followed instructions in previous medical treatments or research studies.
• People who have taken part in another clinical trial or received an experimental medication within the past 30 days.

Important: Always verify eligibility with the trial site directly before applying.